ethyl (2Z)-2-chloro-2-[2-(4-fluorophenyl)hydrazin-1-ylidene]acetate, 95.0%, 5g

8-Chloro-2-methoxy-1,5-naphthyridine, 95.0%, 10g

(2S,3S)-3-(tert-Butyl)-2-isopropyl-4-(2-methoxyphenyl)-2,3-dihydrobenzo[d][1,3]oxaphosphole, 95.00%, 500mg

Fmoc-(RS)-3-amino-3-(4-nitrophenyl)-propionic acid, 97%, 10g

(R)-3-((tert-Butoxycarbonyl)amino)-3-(furan-2-yl)propanoic acid, 95.0%, 100mg

Ethyl 4-bromo-3-ethylbenzoate, 95%, 5g

(S)-5-(Benzyloxy)-2-(2,2-diphenylacetyl)-6-methoxy-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid, 97%, 5mg

tert-Butyl oxazol-5-ylcarbamate, 95.0%, 100mg

4-Bromo-2-(difluoromethoxy)-6-methylpyridine, 97%, 250mg

(2-Chloro-4-methylphenyl)methanamine, 95.0%, 1g

Benzenesulfonic acid, 4-methyl-, copper(2+) salt (2:1), 95%, 10g

[2-(2,6-dimethylphenoxy)ethyl]amine hydrochloride, 95.0%, 5g

2-(Phenylethynyl)benzaldehyde>98.0%(HPLC)1g